Inclusion Criteria:  Patients with DLBCL Age ≥ 18 Received first line R-CHOP like immunochemotherapy from 2014-2020  Exclusion Criteria:  Patients with lymphoma in the central nervous system at time of diagnosis Patients with transformed indolent lymphomas